Trial intelligence / Profile preview

Bioequivalence study of ibuprofen granules under fed and fasting conditions

ChiCTR2200059708Phase 4Completed

Sponsor
Guangzhou Panyu District Central Hospital
Start
Oct 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of ibuprofen in fever, pain, migraine and 1 more (4 arms), sponsored by Guangzhou Panyu District Central Hospital. Primary endpoint: Blood levels of ibuprofen. Started Oct 2018; status: completed.

02

Drugs

ibuprofen
03

Conditions

feverpainmigrainedysmenorrhea

Beyond the preview

Go deeper on ChiCTR2200059708.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200059708.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call